User:Mandy Bechman/Sandbox 1: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
== | ==Importance== | ||
===Tirzepatide=== | ===Tirzepatide=== | ||
One of the most promising treatments to GIP malfunction is <scene name='10/1038867/Tirzepatide/2'>Tirzepatide</scene>, also known as Mounharo, created by Eli Lily. It is an antidiabetic as well as weight loss drug. The structure of Tirzepatide functions as an incretin receptor agonist to GIP by activating GIP's receptor and producing insulin. | One of the most promising treatments to GIP malfunction is <scene name='10/1038867/Tirzepatide/2'>Tirzepatide</scene>, also known as Mounharo, created by Eli Lily. It is an antidiabetic as well as weight loss drug. The structure of Tirzepatide functions as an incretin receptor agonist to GIP by activating GIP's receptor and producing insulin. | ||
